Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry StudyTessa Straatmijer, Joep Grootjans, Adriaan A. van Bodegraven et al.|Clinical Gastroenterology and Hepatology|2022Cited by 51
Combined Clinical and Histopathological Risk Stratification for Prediction of (severe) Endoscopic Postoperative Recurrence in Patients with Crohn’s Disease after Ileocolic ResectionMichiel T. Bak, Lindsey Oudijk, Ariadne H.A.G. Ooms et al.|Annals of Surgery|2025Cited by 5
Prospective real-world experience with risankizumab in difficult-to-treat Crohn’s disease: results from the Dutch Initiative on Crohn and Colitis RegistryLoriane Marina Michèle Verleye, Tessa Straatmijer, Marieke J Pierik et al.|Inflammatory Bowel Diseases|2026Cited by 0